@xconomy.com 3 years ago
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
@xconomy.com 3 years ago
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
@f2harrell 4 years ago
My #Statistics new year goals from 2018-9 remain intact; greatest progress has been more usage of Bayesian methods and more realism about #MachineLearning and #personalized / precision medicine : http://fharrell.com/post/new-year-goals
@techcrunch.com 6 years ago
Tradewind Bioscience attacks the physiology of tumors to treat cancer